Literature DB >> 9595615

Detecting and describing heterogeneity in meta-analysis.

R J Hardy1, S G Thompson.   

Abstract

The investigation of heterogeneity is a crucial part of any meta-analysis. While it has been stated that the test for heterogeneity has low power, this has not been well quantified. Moreover the assumptions of normality implicit in the standard methods of meta-analysis are often not scrutinized in practice. Here we simulate how the power of the test for heterogeneity depends on the number of studies included, the total information (that is total weight or inverse variance) available and the distribution of weights among the different studies. We show that the power increases with the total information available rather than simply the number of studies, and that it is substantially lowered if, as is quite common in practice, one study comprises a large proportion of the total information. We also describe normal plots that are useful in assessing whether the data conform to a fixed effect or random effects model, together with appropriate tests, and give an application to the analysis of a multi-centre trial of blood pressure reduction. We conclude that the test of heterogeneity should not be the sole determinant of model choice in meta-analysis, and inspection of relevant normal plots, as well as clinical insight, may be more relevant to both the investigation and modelling of heterogeneity.

Mesh:

Year:  1998        PMID: 9595615     DOI: 10.1002/(sici)1097-0258(19980430)17:8<841::aid-sim781>3.0.co;2-d

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  167 in total

1.  Graft material and results of platelet inhibitor trials in peripheral arterial reconstructions: reappraisal of results from a meta-analysis.

Authors:  H R Watson; A M Skene; G Belcher
Journal:  Br J Clin Pharmacol       Date:  2000-05       Impact factor: 4.335

Review 2.  Strategies for quantifying the relationship between medications and suicidal behaviour: what has been learned?

Authors:  Robert D Gibbons; J John Mann
Journal:  Drug Saf       Date:  2011-05-01       Impact factor: 5.606

Review 3.  Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies.

Authors:  Mahyar Etminan; Sudeep Gill; Ali Samii
Journal:  BMJ       Date:  2003-07-19

Review 4.  Measuring inconsistency in meta-analyses.

Authors:  Julian P T Higgins; Simon G Thompson; Jonathan J Deeks; Douglas G Altman
Journal:  BMJ       Date:  2003-09-06

Review 5.  Frequency of treatment-effect modification affecting indirect comparisons: a systematic review.

Authors:  Michael Coory; Susan Jordan
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

Review 6.  Effects of aerobic exercise on non-high-density lipoprotein cholesterol in children and adolescents: a meta-analysis of randomized controlled trials.

Authors:  George A Kelley; Kristi S Kelley
Journal:  Prog Cardiovasc Nurs       Date:  2008

Review 7.  A systematic review of conflicting meta-analyses in orthopaedic surgery.

Authors:  Patrick Vavken; Ronald Dorotka
Journal:  Clin Orthop Relat Res       Date:  2009-02-28       Impact factor: 4.176

8.  A nondegenerate penalized likelihood estimator for variance parameters in multilevel models.

Authors:  Yeojin Chung; Sophia Rabe-Hesketh; Vincent Dorie; Andrew Gelman; Jingchen Liu
Journal:  Psychometrika       Date:  2013-03-12       Impact factor: 2.500

9.  Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis.

Authors:  Raymond L Ownby; Elizabeth Crocco; Amarilis Acevedo; Vineeth John; David Loewenstein
Journal:  Arch Gen Psychiatry       Date:  2006-05

Review 10.  Determinants of hepatitis C virus treatment completion and efficacy in drug users assessed by meta-analysis.

Authors:  Rositsa B Dimova; Marija Zeremski; Ira M Jacobson; Holly Hagan; Don C Des Jarlais; Andrew H Talal
Journal:  Clin Infect Dis       Date:  2012-12-07       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.